Conformational changes in plasminogen, their effect on activation, and the agents that modulate activation rates — a review

[1]  K. Kolev,et al.  Dual effect of synthetic plasmin substrates on plasminogen activation. , 1995, Biochimica et biophysica acta.

[2]  L. K. Rasmussen,et al.  The plasminogen activation system in bovine milk: differential localization of tissue-type plasminogen activator and urokinase in milk fractions is caused by binding to casein and urokinase receptor. , 1994, Biochimica et biophysica acta.

[3]  S. Pizzo,et al.  Heparin as an hyperbolic modulator of plasminogen activation by t-PA , 1994 .

[4]  C. Ponting,et al.  Conformational studies of human plasminogen and plasminogen fragments: evidence for a novel third conformation of plasminogen. , 1994, Biochemistry.

[5]  T. Urano,et al.  Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA. , 1994, Thrombosis research.

[6]  M. Stack,et al.  The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen. , 1994, Archives of biochemistry and biophysics.

[7]  J. Weisel,et al.  Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy. , 1994, Journal of molecular biology.

[8]  K. Danø,et al.  Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin. , 1993, The Biochemical journal.

[9]  W. Owen,et al.  Facilitation of Plasminogen Activation by a Plasmin Substrate Containing a Lysyl Residue , 1993, Thrombosis and Haemostasis.

[10]  D. Rijken,et al.  Interaction of Plasminogen Activators and Plasminogen with Heparin: Effect of Ionic Strength , 1993, Thrombosis and Haemostasis.

[11]  C. Smith,et al.  Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators. , 1993, Archives of biochemistry and biophysics.

[12]  F. Castellino,et al.  Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with omega-amino acids. , 1993, Biochemistry.

[13]  M. Stack,et al.  Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin. , 1993, The Journal of biological chemistry.

[14]  T. L. Moser,et al.  The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator. , 1993, The Journal of biological chemistry.

[15]  G. Markus,et al.  Casein, a powerful enhancer of the rate of plasminogen activation , 1993 .

[16]  T. Urano,et al.  Conformational change of plasminogen: effects of N-terminal peptides of Glu-plasminogen. , 1993, Thrombosis research.

[17]  K. Danø,et al.  Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin. , 1993, The Journal of biological chemistry.

[18]  K. Danø,et al.  Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation. , 1993, The Journal of biological chemistry.

[19]  E. Marchina,et al.  Interaction of tissue-type plasminogen activator with fibronectin and fibronectin fragments , 1993 .

[20]  M. Nesheim,et al.  Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. , 1992, The Journal of biological chemistry.

[21]  S. Thorsen.  The Mechanism of Plasminogen Activation and the Variability of the Fibrin Effector during Tissue‐type Plasminogen Activator—mediated Fibrinolysis , 1992, Annals of the New York Academy of Sciences.

[22]  C. Ponting,et al.  Plasminogen: a structural review. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[23]  C. Ponting,et al.  The compact domain conformation of human Glu-plasminogen in solution. , 1992, Biochimica et biophysica acta.

[24]  T. L. Moser,et al.  Binding of human plasminogen to basement-membrane (type IV) collagen. , 1992, The Biochemical journal.

[25]  A. Tulinsky,et al.  Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution. , 1991, Biochemistry.

[26]  A. Tulinsky,et al.  The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4. , 1991, Biochemistry.

[27]  C. Smith,et al.  Actin accelerates plasmin generation by tissue plasminogen activator. , 1991, The Journal of biological chemistry.

[28]  K. Danø,et al.  Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. , 1991, The Journal of biological chemistry.

[29]  K. Danø,et al.  Plasminogen Activation by Receptor-Bound Urokinase , 1991, Seminars in thrombosis and hemostasis.

[30]  S. Pizzo,et al.  Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation. , 1991, The Biochemical journal.

[31]  E. Angles-cano,et al.  The activation of plasminogen by tissue plasminogen activator is not enhanced by different heparin species as assessed in vitro with a solid-phase fibrin method , 1991 .

[32]  C. Smith,et al.  Actin is a noncompetitive plasmin inhibitor. , 1991, The Journal of biological chemistry.

[33]  T. Urano,et al.  Effects of N-terminal peptide of Glu-plasminogen on the activation of Glu-plasminogen and its conversion to Lys-plasminogen. , 1991, Thrombosis research.

[34]  G. Gervasi,et al.  "In vitro" fibrinolytic activity of a new low molecular weight heparan sulfate. , 1990, Thrombosis research.

[35]  S. Pizzo,et al.  Regulation of plasminogen activation by components of the extracellular matrix. , 1990, Biochemistry.

[36]  W. Mangel,et al.  Characterization of an extremely large, ligand-induced conformational change in plasminogen. , 1990, Science.

[37]  D. Walz,et al.  Thrombospondin interaction with plasminogen. Evidence for binding to a specific region of the kringle structure of plasminogen , 1989 .

[38]  M. Scully,et al.  Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. , 1989, The Journal of biological chemistry.

[39]  F. Castellino,et al.  Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator. , 1988, Biochemistry.

[40]  R. Fears.  Kinetic studies on the effect of heparin and fibrin on plasminogen activators. , 1988, The Biochemical journal.

[41]  F. Castellino,et al.  The control of the urokinase-catalyzed activation of human glutamic acid 1-plasminogen by positive and negative effectors. , 1987, The Journal of biological chemistry.

[42]  R. Silverstein,et al.  Binding of plasminogen to extracellular matrix. , 1986, The Journal of biological chemistry.

[43]  S. Strickland,et al.  Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. , 1986, Biochemistry.

[44]  H. Stöhr,et al.  Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationship between plasminogen activators and heparin. , 1986, Thrombosis research.

[45]  I. Clemmensen,et al.  Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. , 1986, European journal of biochemistry.

[46]  J. Zeuthen,et al.  Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. , 1985, The Journal of biological chemistry.

[47]  R. Silverstein,et al.  Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. , 1985, The Journal of biological chemistry.

[48]  R. Silverstein,et al.  Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. , 1985, The Journal of clinical investigation.

[49]  F. Castellino,et al.  A monoclonal antibody to the epsilon-aminocaproic acid binding site on the kringle 4 region of human plasminogen that accelerates the activation of Glu1-plasminogen by urokinase. , 1985, Archives of biochemistry and biophysics.

[50]  R. Silverstein,et al.  Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. , 1984, The Journal of clinical investigation.

[51]  U. Christensen.  The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function. , 1984, The Biochemical journal.

[52]  L. Patthy,et al.  Importance of intramolecular interactions in the control of the fibrin affinity and activation of human plasminogen. , 1984, The Journal of biological chemistry.

[53]  J. Verheijen,et al.  Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2. , 1983, Biochimica et biophysica acta.

[54]  M. Rånby,et al.  Studies on the kinetics of plasminogen activation by tissue plasminogen activator. , 1982, Biochimica et biophysica acta.

[55]  S. Peltz,et al.  Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids. , 1982, Biochemistry.

[56]  Z. Váli,et al.  Location of the intermediate and high affinity omega-aminocarboxylic acid-binding sites in human plasminogen. , 1982, The Journal of biological chemistry.

[57]  L. Patthy,et al.  Kringle 5 of human plasminogen carries a benzamidine-binding site. , 1981, Biochemical and biophysical research communications.

[58]  E. Plow,et al.  Immunochemical characterization of a low affinity lysine binding site within plasminogen. , 1981, The Journal of biological chemistry.

[59]  T. Heinze,et al.  Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator? , 1981, Archives of biochemistry and biophysics.

[60]  R. Priore,et al.  The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. , 1979, The Journal of biological chemistry.

[61]  G. Markus,et al.  Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen. , 1978, The Journal of biological chemistry.

[62]  G. Markus,et al.  Comparison of some properties of native (Glu) and modified (Lys) human plasminogen. , 1978, The Journal of biological chemistry.

[63]  E. Rickli,et al.  A new method of isolation and some properties of the heavy chain of human plasmin. , 1975, European journal of biochemistry.

[64]  W. Holleman,et al.  The relationship between the lysine and the p-aminobenzamidine binding sites on human plasminogen. , 1975, Thrombosis research.

[65]  S. Thorsen,et al.  Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds. , 1974, Scandinavian journal of clinical and laboratory investigation.

[66]  J. Vermylen,et al.  Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid. , 1974, Biochimica et biophysica acta.

[67]  B. Wiman,et al.  Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid. , 1973, European journal of biochemistry.

[68]  J. K. Thomas,et al.  Rotational diffusion analysis of the conformational alterations produced in plasminogen by certain antifibrinolytic amino acids. , 1973, Biochemistry.

[69]  F. Castellino,et al.  Measurement of the binding of antifibrinolytic amino acids to various plasminogens. , 1972, Archives of biochemistry and biophysics.

[70]  B. Wiman,et al.  Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. , 1972, Biochimica et biophysica acta.

[71]  T. Astrup,et al.  Fibrinogenolysis and Fibrinolysis with Tissue Plasminogen Activator, Urokinase, Streptokinase-Activated Human Globulin, and Plasmin 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[72]  Francis J. Castellino,et al.  The Mechanism of the Inhibition of Plasmin Activity by ε-Aminocaproic Acid , 1971 .

[73]  F. Markwardt,et al.  Comparative studies on the inhibition of trypsin, plasmin, and thrombin by derivatives of benzylamine and benzamidine. , 1968, European journal of biochemistry.

[74]  K. Robbins,et al.  The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. , 1967, The Journal of biological chemistry.

[75]  N. Alkjaersig.  The purification and properties of human plasminogen. , 1964, The Biochemical journal.